Cho Soo Youn, Park So Yeon, Bae Young Kyung, Kim Jee Yeon, Kim Eun Kyung, Kim Woo Gyeong, Kwon Youngmee, Lee Ahwon, Lee Hee Jin, Lee Ji Shin, Park Jee Young, Gong Gyungyub, Yoon Hye Kyoung
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
J Breast Cancer. 2021 Feb;24(1):1-21. doi: 10.4048/jbc.2021.24.e5.
Given the recent advances in management and understanding of breast cancer, a standardized pathology report reflecting these changes is critical. To meet this need, the Breast Pathology Study Group of the Korean Society of Pathologists has developed a standardized pathology reporting format for breast cancer, consisting of 'standard data elements,' 'conditional data elements,' and a biomarker report form. The 'standard data elements' consist of the basic pathologic features used for prognostication, while other factors related to prognosis or diagnosis are described in the 'conditional data elements.' In addition to standard data elements, all recommended issues are also presented. We expect that this standardized pathology report for breast cancer will improve diagnostic concordance and communication between pathologists and clinicians, as well as between pathologists inter-institutionally.
鉴于乳腺癌管理和认识方面的最新进展,一份反映这些变化的标准化病理报告至关重要。为满足这一需求,韩国病理学家协会乳腺病理研究组制定了乳腺癌标准化病理报告格式,包括“标准数据元素”、“条件数据元素”和一份生物标志物报告表。“标准数据元素”由用于预后评估的基本病理特征组成,而与预后或诊断相关的其他因素则在“条件数据元素”中描述。除标准数据元素外,还列出了所有推荐问题。我们期望这份乳腺癌标准化病理报告将提高诊断一致性,改善病理学家与临床医生之间以及机构间病理学家之间的沟通。